Cardiff Oncology公布Onvansertib一线治疗Ras突变转移性结直肠癌的随机对照二期试验积极数据,将于2026年ASCO年会上展示

美股速递
Jun 02

Cardiff Oncology宣布,其Onvansertib用于一线治疗Ras突变转移性结直肠癌的随机对照二期临床试验取得积极结果,相关数据将在2026年美国临床肿瘤学会年会上进行展示。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10